Background: Hyperbaric oxygen therapy (HBOT), which involves administering oxygen at pressures higher than normal atmospheric levels, is a highly effective treatment for a number of approved medical conditions, including air or gas embolism, carbon monoxide poisoning; cyanide poisoning; smoke inhalation, clostridial myositis and myonecrosis (gas gangrene), decompression sickness. Objectives: This study explores the awareness and acceptance of Hyperbaric Oxygen Therapy (HBOT) as a treatment modality among a cohort of medical doctors. Methodology: The study used a structured survey to assess participants’ knowledge of HBOT indications, perceptions about its efficacy, and willingness to refer patients in the future for diseases that would benefit from this treatment. Results: Findings indicate a rising awareness of HBOT’s role in the management of selected medical conditions, including chronic wounds, radiation injuries, and certain infections. Notably, most respondents expressed openness to incorporating HBOT into patient care plans where appropriate. Conclusion: These results suggest growing recognition of HBOT within the medical community and highlight the need for continued education and access to facilitate its broader integration into clinical practice.
Betiku et al. (Tue,) studied this question.